A comparison of three methods of measuring plasma glycosylated hemoglobin

Asian Biomedicine

Volumn 2, Issue 1, 2008, Pages 43-49

  Thevarajah, T Malathi ^a   Hasrsah, Thuhairah ^a   Mohd Ismail, Aletza ^a   Yean, Chew Yee ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Diabetes; Evaluation; HbA1c; HPLC test

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ANALYZER; ARTICLE; AUTOANALYZER; CONTROLLED STUDY; DIABETES MELLITUS; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; ION EXCHANGE CHROMATOGRAPHY; THALASSEMIA; TURBIDIMETRY; UREMIA;

EID: 70349473252     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Eng J Med. 1993; 329:977-86.
2. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2001; 28(Suppl 1):1-33.
3. Huri ZH. Min YS, Pendek R. Episodes of hypoglycemia and hyperglycemia with the use of sliding scale insulin in hospitalized diabetes patients. Asian Biomed. 2007; 1:307-11.
4. International Diabetes Federation Clinical Guidelines Task Force, 2005. Global Guideline for Type II Diabetes: http://www.idf.org .
5. Goodall I. HbA1c Standardisation. Destination - global IFCC standardisation. How, why, where and when. A tortuous pathway from kit manufacturers, via interlaboratory lyophilized and whole blood comparisons to designated National comparison schemes. Clin Biochem Rev. 2005; 26:5-19.
6. Little RR. The National Glycohaemoglobin standardisation programme (NGSP). In WG John, editor. Monitoring Glycaemic Control in the Diabetic Patient. London:Harcourt Health Communiction, Mosby International Health (Lt). 2001; p. 123-36.
7. American Diabetes Association. Position statement: tests of glycemia in diabetes. Diabetes Care. 1998; 21: S69-71.
8. Little RR, Rohlfing CL, Wiedmeyer HM, Myres GL, Sacks DB, Goldstein DE. The National glycohaemoglobin standardisation programme: a five year progress report. Clin Chem. 2001; 47:1985-92.
9. NCCLS evaluation of precision performance of clinical chemistry devices. Approved Guidellines NCCLS publication EP5-A, Villanova PA, NCCLS. 1999.
10. IFCC Working Group on Standardization of HbA1c web site: http://www.ifcchba1c.com.
11. Panteghini M, John WG. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med. 2007; 45:942-4.
12. Roberts WL, Frank EL, Moulton l, Papadea C, Noffsinger JK, Ou C-N. Effects of nine hemoglobin variants on five glycohemoglobin. Clin Chem. 2000; 46:569-72. (Pubitemid 30210733)
13. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001; 47:153-63.
14. Roberts WL, De BK, Brown D, Hanbury CM, Hoyer JD, John WG, et al. Effects of hemoglobin C and S traits on eight glycohemoglobin methods. Clin Chem. 2002; 48:383-5.
15. Puukka R, Effect of hemoglobin F on measurements of hemoglobin A1c with physician's office analysers (technical brief). Clin Chem. 1994; 40:342-3.
16. Weylcamp CW, Penders TJ, Siebelder CW, Muskiet FA, van der Sik W. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography and enzyme immunoassay. Clin Chem. 1993; 39:138-42.